Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-26 Purchase | 2024-02-27 4:43 pm | OCULAR THERAPEUTIX INC | OCUL | SUMMER ROAD LLC 10% Owner | 930,851 | $7.52 | $7,000,000 | 8,591,401 (Indirect) | View |
| 2024-02-05 Sale | 2024-02-06 6:38 pm | OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer | 5,910 | $4.86 | $28,723 | 243,689 (Direct) | View |
| 2024-02-05 Sale | 2024-02-06 6:35 pm | OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel | 6,029 | $4.86 | $29,301 | 336,493 (Direct) | View |
| 2024-02-05 Sale | 2024-02-06 6:32 pm | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 6,346 | $4.86 | $30,842 | 353,054 (Direct) | View |
| 2024-02-05 Sale | 2024-02-06 6:29 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 6,212 | $4.86 | $30,190 | 380,356 (Direct) | View |
| 2024-02-05 Sale | 2024-02-06 6:26 pm | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 19,642 | $4.86 | $95,460 | 1,144,601 (Indirect Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:03 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 6,433 | $4.95 | $31,843 | 139,932 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:02 pm | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 7,764 | $4.95 | $38,432 | 92,767 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:01 pm | OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel | 6,831 | $4.95 | $33,813 | 109,218 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:01 pm | OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer | 5,147 | $4.95 | $25,478 | 89,619 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:00 pm | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 18,338 | $4.95 | $90,773 | 434,443 (Indirect Direct) | View |
| 2023-12-14 Purchase | 2023-12-18 4:52 pm | OCULAR THERAPEUTIX INC | OCUL | SUMMER ROAD LLC 10% Owner | 1,538,461 | $3.25 | $4,999,998 | 7,660,550 (Indirect) | View |
| 2023-08-30 Purchase | 2023-09-05 08:27 am | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 6,500 | $3.81 | $24,765 | 452,781 (Indirect Direct) | View |
| 2023-07-07 Sale | 2023-07-11 8:00 pm | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 832 | $4.93 | $4,102 | 100,531 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 7:38 pm | OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer | 5,829 | $4.24 | $24,715 | 94,766 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 7:33 pm | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 6,416 | $4.24 | $27,204 | 101,363 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 7:32 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 6,476 | $4.24 | $27,458 | 139,387 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 7:31 pm | OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel | 6,181 | $4.24 | $26,207 | 109,071 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 7:29 pm | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 19,669 | $4.24 | $83,397 | 446,281 (Direct) | View |
| 2022-11-07 Purchase | 2022-11-09 4:48 pm | OCULAR THERAPEUTIX INC | OCUL | SUMMER ROAD LLC 10% Owner | 7,328 | $3.5 | $25,648 | 6,122,089 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-22 Option Award | 2024-02-26 8:07 pm | N/A 2024-02-21 | OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin Executive Chairman | 2,137,448 | $0 | 2,137,448 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 8:06 pm | N/A 2024-02-21 | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 324,850 | $0 | 424,850 (Direct) | View |
Ownership | 2024-02-26 8:02 pm | N/A N/A | OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer | 0 | $0 | 100,000 (Direct) | View |
| 2024-02-03 Option Award | 2024-02-06 6:38 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer | 159,980 | $0 | 243,689 (Direct) | View |
| 2024-02-03 Option Award | 2024-02-06 6:35 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel | 233,304 | $0 | 336,493 (Direct) | View |
| 2024-02-03 Option Award | 2024-02-06 6:32 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 266,633 | $0 | 353,054 (Direct) | View |
| 2024-02-03 Option Award | 2024-02-06 6:29 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 246,636 | $0 | 380,356 (Direct) | View |
| 2024-02-03 Option Award | 2024-02-06 6:26 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 729,800 | $0 | 1,144,601 (Direct) | View |
| 2023-08-02 Option Award | 2023-08-18 8:45 pm | N/A 2033-08-01 | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Director | 17,350 | $0 | 17,350 (Direct) | View |
| 2023-07-10 Option Award | 2023-07-12 5:18 pm | N/A 2033-07-09 | OCULAR THERAPEUTIX INC | OCUL | Graves Adrienne L Director | 96,000 | $0 | 96,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 7:09 pm | N/A 2033-06-13 | OCULAR THERAPEUTIX INC | OCUL | Warden Charles M Director | 48,000 | $0 | 96,464 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 7:08 pm | N/A 2033-06-13 | OCULAR THERAPEUTIX INC | OCUL | Williams Leslie J. Director | 48,000 | $0 | 61,433 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 7:05 pm | N/A 2033-06-13 | OCULAR THERAPEUTIX INC | OCUL | RAINES MERILEE Director | 48,000 | $0 | 56,933 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 7:05 pm | N/A 2033-06-13 | OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director | 48,000 | $0 | 156,402 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 7:03 pm | N/A 2033-06-13 | OCULAR THERAPEUTIX INC | OCUL | Hong Seung Suh Director | 48,000 | $0 | 56,933 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 7:02 pm | N/A 2033-06-13 | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Director | 48,000 | $0 | 95,933 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 7:36 pm | N/A 2033-01-29 | OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer | 177,777 | $0 | 233,928 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 7:35 pm | N/A 2033-01-29 | OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel | 222,223 | $0 | 281,919 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 7:34 pm | N/A 2033-01-29 | OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer | 272,223 | $0 | 324,446 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 7:33 pm | N/A 2033-01-29 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 222,223 | $0 | 312,530 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 7:32 pm | N/A 2033-01-29 | OCULAR THERAPEUTIX INC | OCUL | Mattessich Antony C. President and CEO | 713,200 | $0 | 1,002,850 (Direct) | View |
| 2022-10-17 Option Award | 2022-10-18 5:12 pm | N/A 2032-10-16 | OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-10-13 Option Award | 2022-10-14 9:04 pm | N/A 2032-10-12 | OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer | 7,000 | $0 | 7,000 (Direct) | View |